// App-Quantinova.ai

AB0420 : RISK OF DEVELOPING TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Researchers

Presenter

  • L. Kondrateva

Principal Investigators

  • T. Popkova

  • E. Nasonov

  • A. Lila

Medical Centers

  • VA Nasonova Institute of Rheumatology, Moscow, Russian Federation, Moscow, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

Disease

  • Lupus

  • Type 2 diabetes mellitus

  • Inflammatory Arthritis

  • Diabetes

  • Hyperglycemia

  • Obesity

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved